MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
about
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancerChemotherapy enhances cross-presentation of nuclear tumor antigensHigh expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer.Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.Cancer/testis antigens and urological malignanciesLEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.Evaluation of MAGE-1 Cancer-Testis Antigen Expression in Invasive Breast Cancer and its Correlation with Prognostic Factors.MAGE-A Antigens and Cancer Immunotherapy.Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens.Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cellsTrial Watch: Peptide vaccines in cancer therapy.Determination of cell type-specific proteome signatures of primary human leukocytes, endothelial cells, keratinocytes, hepatocytes, fibroblasts and melanocytes by comparative proteome profiling.MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.A constructed HLA-A2-restricted pMAGE-A1(278-286) tetramer detects specific cytotoxic T lymphocytes in tumour tissues in situ.Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma.
P2860
Q34015590-9F1119AF-15ED-46BB-B778-42C687477A0EQ34226903-59131F7B-33D6-4D6D-B7B1-9A994BF7767BQ34235940-F77B0DB4-CDF8-482E-A864-7E73BF1DF405Q35739798-0339E024-2BE3-4A58-A308-FDBB67932A58Q36086874-D257323B-B31C-4210-829A-1F2754044D5FQ36337004-583A869F-2C6B-48CE-BD20-3F464F642994Q37061372-74EF7A49-9A33-4593-833D-8D128B805911Q37322880-3D524840-CF0F-4E56-B3DD-72130A8AF2D2Q37685379-65E96A2F-F31A-404B-807E-5AB765F12691Q39610714-63822559-BCD8-4081-B700-0EC86BDE34A3Q41682198-97502AF0-6A62-486C-8208-1088B00AFC8FQ42734544-2B78DBC1-371F-40AF-898F-85009E869D8DQ46429133-A6E475E4-8DA6-423D-A2E7-0BAB6E5F9DCEQ54284949-3F286D3E-F09F-42CA-A93A-E1C1C5A95307Q54517111-BB14AF52-70B8-4AFD-A339-2E00F1D057DEQ55241840-E27C6241-3FEC-47D5-AAD9-F694B29C5955
P2860
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@ast
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@en
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@nl
type
label
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@ast
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@en
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@nl
prefLabel
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@ast
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@en
MAGE-A10 is a nuclear protein ...... n and urothelial malignancies.
@nl
P2093
P2860
P50
P356
P1476
MAGE-A10 is a nuclear protein ...... in and urothelial malignancies
@en
P2093
Elke Schultz-Thater
Giandomenica Iezzi
Giulio C Spagnoli
Luigi Terracciano
Vincenza Carafa
P2860
P304
P356
10.1002/IJC.25777
P577
2011-01-12T00:00:00Z